Jill Kolesar, PharmD

  • Director, Early Phase Clinical Trials Center
  • Co-Director of the Translational Oncology Program
  • Co-Director, Molecular Tumor Board

About

Faculty Rank

  • Professor

Training & Education

Degree

Master of Science University of Wisconsin School of Medicine and Public Health
PharmD Univ Of Texas At San Antonio
Bachelor of Science Pharmacy University of Wisconsin

Certifications and Special Training

Mini-Sabbatical University of Minnesota-Twin Cities

Fellowship

Fellowship The University of Texas Science Center

Residency

Residency Medical Center Hospital

Research

Research Focus

Dr. Kolesar’s research focuses on the drug development of anticancer agents with an emphasis on targeted therapies and biomarkers. She has authored more than 200 abstracts, research articles, and book chapters, and as a principal investigator she has received more than $1.5 million in research funding from the NCI, American Cancer Society and other sources. Jill has received teaching and research awards from local, national and international organizations including the Innovations in Teaching Award from the American Association of Colleges of Pharmacy.

Publications